Seldar Pharma's Series A Round

Seldar Pharma raised a round of funding on June 05, 2012.

Seldar Pharma is a virtual company created to develop and commercialize ASP7147, a bombesin BB2 receptor antagonist for the treatment of irritable bowel syndrome with diarrhea. The compound pipeline o…

Articles about Seldar Pharma's Series A Round: